MedTrace Logo

Atherosclerosis and Acute Ischemic Stroke Study

NCT03685006 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2022-04-25

No results posted yet for this study

Summary

A significant proportion of strokes are thromboembolic in nature, arising from atherosclerotic plaque at the carotid bifurcation. It is now wellknown that inflammation plays a key role in atherogenesis and plaque destabilization. However the identification and characterization of the different inflammatory factors, as well as their relative importance, have not been clarified. This main aim of this study is to identify new risk markers for atherosclerosis and to characterize more precise methods for detection of the unstable carotid plaque with increased stroke-risk.

Conditions

Sponsors & Collaborators

  • University of Oslo

    collaborator OTHER

  • University Hospital, Akershus

    collaborator OTHER

  • Ostfold Hospital Trust

    collaborator OTHER

  • Vestre Viken Hospital Trust

    collaborator OTHER

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Mona Skjelland, MD/postdoc · Oslo University Hospital, Oslo, Norway

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-01-01
Primary Completion
2026-01-01
Completion
2030-01-01

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03685006 on ClinicalTrials.gov